Disclosure: The speaker has signed a disclosure form and indicated he currently serves on the speaker’s bureau and the advisory board for Merck and GlaskoSmithKlein. He does not intend to discuss the unlabeled/investigational use(s) of a drug or device in his presentation.

Clinical Content Reviewer: Juan Dumois, MD

Learning Objectives: As a result of attending this presentation, participants will be able to:

identify risk factors for acquisition of HPV infection in women

identify HPV types according to clinical manifestation and oncogenic potential

discuss the rationale for HPV vaccination and the immunogenicity and efficacy of the HPV vaccines

cite the current guidelines and recommendations for HPV vaccination;

identify and overcome barriers to the acceptance of HPV vaccination, including bioethical issues related to HPV infection

Minimum System Requirements

While the presentations may be viewable on systems that don't meet these criteria, we recommend that you use a computer that meets the following standards: